Decision of the EEA Joint Committee No 121/2019 of 8 May 2019 amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2019]
Date: 2019-05-08
Institutions: EEA Joint Committee
Subjects: European Economic Area, chemical product, dangerous substance, endocrine disease, health risk, market approval, plant health control, plant health product, revision of an agreement, withdrawal from the market




L_2022279EN.01002301.xml










27.10.2022   


EN


Official Journal of the European Union


L 279/23








            DECISION OF THE EEA JOINT COMMITTEE No 121/2019
of 8 May 2019
         
amending Annex II (Technical regulations, standards, testing and certification) to the EEA Agreement [2022/2019]


THE EEA JOINT COMMITTEE,

Having regard to the Agreement on the European Economic Area (‘the EEA Agreement’), and in particular Article 98 thereof,

Whereas:







(1)


Commission Implementing Regulation (EU) 2018/1659 of 7 November 2018 amending Implementing Regulation (EU) No 844/2012 in view of the scientific criteria for the determination of endocrine disrupting properties introduced by Regulation (EU) 2018/605 (1) is to be incorporated into the EEA Agreement.












(2)


Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval periods of the active substances amidosulfuron, bifenox, chlorpyrifos, chlorpyrifos-methyl, clofentezine, dicamba, difenoconazole, diflubenzuron, diflufenican, dimoxystrobin, fenoxaprop-p, fenpropidin, lenacil, mancozeb, mecoprop-p, metiram, nicosulfuron, oxamyl, picloram, pyraclostrobin, pyriproxyfen and tritosulfuron (2) is to be incorporated into the EEA Agreement.












(3)


Commission Implementing Regulation (EU) 2018/1913 of 6 December 2018 renewing the approval of the active substance tribenuron in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (3) is to be incorporated into the EEA Agreement.












(4)


Commission Implementing Regulation (EU) 2018/1914 of 6 December 2018 concerning the non-renewal of approval of the active substance quinoxyfen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (4) is to be incorporated into the EEA Agreement.












(5)


Commission Implementing Regulation (EU) 2018/1915 of 6 December 2018 approving the active substance Metschnikowia fructicola strain NRRL Y-27328 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (5) is to be incorporated into the EEA Agreement.












(6)


Commission Implementing Regulation (EU) 2018/1916 of 6 December 2018 amending Implementing Regulation (EU) No 540/2011 as regards the extension of the approval period of the active substance bispyribac (6) is to be incorporated into the EEA Agreement.












(7)


Commission Implementing Regulation (EU) 2018/1917 of 6 December 2018 concerning the non-renewal of approval of the active substance flurtamone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (7) is to be incorporated into the EEA Agreement.












(8)


Annex II to the EEA Agreement should therefore be amended accordingly,





HAS ADOPTED THIS DECISION:



Article 1
Chapter XV of Annex II to the EEA Agreement shall be amended as follows:






1.


The following indents are added in point 13a (Commission Implementing Regulation (EU) No 540/2011):






‘—



32018 R 1796: Commission Implementing Regulation (EU) 2018/1796 of 20 November 2018 (OJ L 294, 21.11.2018, p. 15),










—



32018 R 1913: Commission Implementing Regulation (EU) 2018/1913 of 6 December 2018 (OJ L 311, 7.12.2018, p. 13),










—



32018 R 1914: Commission Implementing Regulation (EU) 2018/1914 of 6 December 2018 (OJ L 311, 7.12.2018, p. 17),










—



32018 R 1915: Commission Implementing Regulation (EU) 2018/1915 of 6 December 2018 (OJ L 311, 7.12.2018, p. 20),










—



32018 R 1916: Commission Implementing Regulation (EU) 2018/1916 of 6 December 2018 (OJ L 311, 7.12.2018, p. 24),










—



32018 R 1917: Commission Implementing Regulation (EU) 2018/1917 of 6 December 2018 (OJ L 311, 7.12.2018, p. 27).’














2.


The following is added in point 13f (Commission Implementing Regulation (EU) No 844/2012):

                              ‘as amended by:






—



32018 R 1659: Commission Implementing Regulation (EU) 2018/1659 of 7 November 2018 (OJ L 278, 8.11.2018, p. 3).’
                                 














3.


The following points are inserted after point 13zzzzzzzzzi (Commission Implementing Regulation (EU) 2018/1532):






‘13zzzzzzzzzj.



32018 R 1913: Commission Implementing Regulation (EU) 2018/1913 of 6 December 2018 renewing the approval of the active substance tribenuron in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 294, 21.11.2018, p. 15).










13zzzzzzzzzk.



32018 R 1914: Commission Implementing Regulation (EU) 2018/1914 of 6 December 2018 concerning the non-renewal of approval of the active substance quinoxyfen, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 311, 7.12.2018, p. 17).










13zzzzzzzzzl.



32018 R 1915: Commission Implementing Regulation (EU) 2018/1915 of 6 December 2018 approving the active substance Metschnikowia fructicola strain NRRL Y-27328 in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending the Annex to Commission Implementing Regulation (EU) No 540/2011 (OJ L 311, 7.12.2018, p. 20).










13zzzzzzzzzm.



32018 R 1917: Commission Implementing Regulation (EU) 2018/1917 of 6 December 2018 concerning the non-renewal of approval of the active substance flurtamone, in accordance with Regulation (EC) No 1107/2009 of the European Parliament and of the Council concerning the placing of plant protection products on the market, and amending Commission Implementing Regulation (EU) No 540/2011 (OJ L 311, 7.12.2018, p. 27).’










Article 2
The texts of Implementing Regulations (EU) 2018/1659, (EU) 2018/1796, (EU) 2018/1913, (EU) 2018/1914, (EU) 2018/1915, (EU) 2018/1916 and (EU) 2018/1917 in the Icelandic and Norwegian languages, to be published in the EEA Supplement to the Official Journal of the European Union, shall be authentic.


Article 3
This Decision shall enter into force on 1 June 2019, provided that all the notifications under Article 103(1) of the EEA Agreement have been made (*).


Article 4
This Decision shall be published in the EEA Section of, and in the EEA Supplement to, the Official Journal of the European Union.




Done at Brussels, 8 May 2019.


For the EEA Joint Committee


The President

Claude MAERTEN
            





(1)  
            OJ L 278, 8.11.2018, p. 3.

(2)  
            OJ L 294, 21.11.2018, p. 15.

(3)  
            OJ L 311, 7.12.2018, p. 13.

(4)  
            OJ L 311, 7.12.2018, p. 17.

(5)  
            OJ L 311, 7.12.2018, p. 20.

(6)  
            OJ L 311, 7.12.2018, p. 24.

(7)  
            OJ L 311, 7.12.2018, p. 27.

(*)  No constitutional requirements indicated.